70 Years of DON and Beyond: Glutaminase Inhibition as a Synergistic Strategy in Cancer Combination Therapy. [PDF]
Campos-Sandoval JA +3 more
europepmc +1 more source
Correction: A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion. [PDF]
Majid D +17 more
europepmc +1 more source
Synthetic auxotrophy reveals metabolic regulation of plasma cell generation, affinity maturation, and cytokine receptor signaling. [PDF]
Cho SH +16 more
europepmc +1 more source
Targeting Glutaminase Isoforms GLS and GLS2 in Luminal Breast Cancer. [PDF]
Masisi BK +5 more
europepmc +1 more source
Plumbagin Is a PKM2 Activator That Modulates Glutamine Metabolism and Dependency in Leukemia. [PDF]
Vrdoljak N, Minden MD, Spagnuolo PA.
europepmc +1 more source
In Vitro Glutamine Adaptability in Murine Liver- but Not Lung-Metastasizing Triple-Negative Breast Cancer Cells. [PDF]
Layosa MA +7 more
europepmc +1 more source
Dysregulated myelopoiesis and enhanced glutaminase-dependent neutrophil survival in preclinical obesity. [PDF]
Babcock M +5 more
europepmc +1 more source
Glutamine-driven reductive TCA cycle metabolism supports aged muscle stem cell function via de novo lipogenesis. [PDF]
Lee DE +10 more
europepmc +1 more source
Unveiling a putative class 3 L-asparaginase in Glutamicibacter sp.: from soil isolation to in silico characterization. [PDF]
Mofidi M +4 more
europepmc +1 more source
Beyond Glycolysis: Targeting Non-Glycolytic Metabolic Pathways in Brain Tumors for Therapeutic Innovation: A Narrative Review. [PDF]
Mayesha II +5 more
europepmc +1 more source

